As doctors and clinicians continue to look for breakthroughs in treatments for COVID-19, could the anti-malarial drug, hydroxycholorquine, prove to be a possible prophylactic? Newt talks with Dr. David Pearce of Sanford Health. Sanford Health is conducting the first controlled hydroxycholoquine clinical trial in the United States.
Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

Episode 972: Congresswoman Elise Stefanik on “Poisoned Ivies”
36:35

Episode 971: The Hospital Cost Crisis
35:07

Episode 970: Founder’s Fire From 1776 to the Age of Trump
38:47